Crispr and Cas Gene Market to Hit $6.47 Billion by 2030: Coherent Market Insights (CMI)
December 04, 2023 11:09 ET
|
CMI
Burlingame, Dec. 04, 2023 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, The global crispr and cas gene market was valued at US$ 1.54 Billion in 2023 and is forecast to reach a value of...
CASGEVY Gets Bahrain approval for treatment, marking it second country in the world
December 02, 2023 12:59 ET
|
National Health Regulatory Authority
CASGEVY Gets Bahrain approval for treatment, marking it second country in the world
CRISPR Genomic Cure Market Size to Reach $14.80 Billion, Globally, by 2030 at 34.7% CAGR: Coherent Market Insights (CMI)
July 27, 2023 05:40 ET
|
CMI
Burlingame, July 27, 2023 (GLOBE NEWSWIRE) -- Coherent Market Insights published a report, titled, “Crispr Genomic Cure Market, By Disease Type (Genetic Disorders, Cancer, Infectious Diseases,...
CRISPR Technology Market to Reach US$ 7.72 Billion by 2030: Coherent Market Insights
July 11, 2023 12:18 ET
|
CMI
Burlingame, July 11, 2023 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, global CRISPR technology market is generated $2.25 billion in 2022, and is anticipated to generate $7.72 billion...
CRISPR Market: 2023 Research Report by Key Players, Global Demand, Industry Size and Share Estimations, Increasing Opportunity Forecast to 2027
June 12, 2023 05:51 ET
|
Absolute Reports Pvt Ltd
Pune, June 12, 2023 (GLOBE NEWSWIRE) -- Global “CRISPR Market” Growth Research 2023-2027: regional developments and industry segments by type and applications. This 103 Pages Report focuses on...
CRISPR Therapeutics Announces Collaboration with Massachusetts General Hospital to Research Use of CRISPR/Cas9 in T Cell Cancer Therapies
August 22, 2017 07:30 ET
|
CRISPR Therapeutics AG
ZUG, Switzerland and CAMBRIDGE, Mass., Aug. 22, 2017 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for...
CRISPR Therapeutics Announces Exclusive License of Lipid Nanoparticle Technologies Developed at MIT
May 08, 2017 08:00 ET
|
CRISPR Therapeutics AG
BASEL, Switzerland and CAMBRIDGE, Mass., May 08, 2017 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for...
CRISPR Therapeutics to Present at the 16th Annual Needham Healthcare Conference
March 30, 2017 08:00 ET
|
CRISPR Therapeutics AG
BASEL, Switzerland and CAMBRIDGE, Mass., March 30, 2017 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on translating CRISPR-Cas9 gene-editing technology...
CRISPR Therapeutics Announces European Patent for CRISPR/Cas Gene Editing
March 28, 2017 08:00 ET
|
CRISPR Therapeutics AG
- Patent to include CRISPR/Cas9 gene editing compositions for use in any non-cellular and cellular setting, including human and other eukaryotic cells BASEL, Switzerland, March 28, 2017 (GLOBE...
CRISPR Therapeutics and Casebia Therapeutics Announce Commercial License Agreement With MaxCyte
March 14, 2017 07:00 ET
|
CRISPR Therapeutics AG
BASEL, Switzerland, CAMBRIDGE, Mass., and GAITHERSBURG, Md., March 14, 2017 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformative...